Bayer A S, Speert D P, Park S, Tu J, Witt M, Nast C C, Norman D C
Department of Medicine, Harbor-UCLA Medical Center, Torrance 90509.
Infect Immun. 1991 Jan;59(1):302-8. doi: 10.1128/iai.59.1.302-308.1991.
We evaluated in vitro the functional role of mucoid exopolysaccharide (MEP) of Pseudomonas aeruginosa in blocking antibiotic-induced and polymorphonuclear leukocyte (PMN)-mediated pseudomonal killing. The serum-resistant P. aeruginosa isolates used were mucoid strain 144MR and its nonmucoid revertant, strain 144NM. By timed kill curves, early bacterial effects of amikacin against mucoid strain 144MR were substantially less than those observed with nonmucoid strain 144NM; this effect was reversible with enzymatic hydrolysis of MEP of strain 144MR by alginase. Also, early tobramycin uptake (15 to 30 min) by mucoid 144MR cells was less than that seen with nonmucoid strain 144NM; pretreatment of 144MR cells with alginase substantially enhanced early tobramycin uptake compared with untreated 144MR cells (P = 0.08). In strain 144NM (but not in strain 114MR) there was a notable postantibiotic leukocidal enhancement effect manifested by increased nonopsonic killing following brief exposure of these cells to supra-MIC amikacin; pretreatment of strain 144MR with alginase rendered these cells more susceptible to amikacin-induced postantibiotic leukocidal enhancement. Similarly, direct PMN-mediated nonopsonic killing of mucoid strain 144MR was significantly less than that observed with strain 144NM (P less than 0.05); pretreatment of 144MR cells with alginase rendered this strain equal to strain 144NM in susceptibility to nonopsonic killing. In addition, exogenous sodium alginate or extracted MEP of strain 144MR interfered with effective nonopsonic killing of strain 144NM by PMNs. Studies also indicated that mucoid strain 144MR was phagocytosed significantly less well than its nonmucoid mate (P less than 0.00001), an effect reversed by pretreatment of the mucoid cells with alginase. These data confirm that P. aeruginosa MEPs functionally decrease the uptake and early bactericidal effect of aminoglycosides in vitro and interfere with effective PMN-mediated nonopsonic phagocytosis and killing of mucoid strains.
我们在体外评估了铜绿假单胞菌的黏液样胞外多糖(MEP)在阻断抗生素诱导及多形核白细胞(PMN)介导的假单胞菌杀伤中的功能作用。所使用的血清耐受型铜绿假单胞菌分离株为黏液样菌株144MR及其非黏液样回复株144NM。通过定时杀菌曲线可知,阿米卡星对黏液样菌株144MR的早期细菌效应显著低于非黏液样菌株144NM;用藻酸酶对144MR菌株的MEP进行酶解后,这种效应是可逆的。此外,黏液样144MR细胞对妥布霉素的早期摄取(15至30分钟)低于非黏液样菌株144NM;与未处理的144MR细胞相比,用藻酸酶预处理144MR细胞可显著增强其对妥布霉素的早期摄取(P = 0.08)。在菌株144NM(而非菌株114MR)中,存在一种显著的抗生素后白细胞杀伤增强效应,表现为这些细胞短暂暴露于超最小抑菌浓度的阿米卡星后,非调理吞噬杀伤作用增强;用藻酸酶预处理菌株144MR可使这些细胞对阿米卡星诱导的抗生素后白细胞杀伤增强更敏感。同样,PMN介导的对黏液样菌株144MR的直接非调理吞噬杀伤作用显著低于对菌株144NM的观察结果(P小于0.05);用藻酸酶预处理144MR细胞可使该菌株在对非调理吞噬杀伤的敏感性上与菌株144NM相当。此外,外源性海藻酸钠或提取的144MR菌株的MEP会干扰PMN对144NM菌株的有效非调理吞噬杀伤作用。研究还表明,黏液样菌株144MR的吞噬作用明显低于其非黏液样配对菌株(P小于0.00001),用藻酸酶预处理黏液样细胞可逆转这种效应。这些数据证实,铜绿假单胞菌的MEP在体外功能上会降低氨基糖苷类药物的摄取和早期杀菌作用,并干扰有效的PMN介导的非调理吞噬作用及对黏液样菌株的杀伤。